MarketCap
Facebook
X
TelegramHancock Jaffe Laboratories, Inc. DSO Ratio 2011-2026 | HJLI
Annual DSO Ratio Hancock Jaffe Laboratories, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | - | 62.7 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 62.7 | 62.7 | 62.7 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
43.1 | $ 11.03 | 1.19 % | $ 1.66 B |  USA |
 |
AxoGen
AXGN
|
40.7 | $ 32.49 | 1.67 % | $ 1.5 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | USA |
 |
Align Technology
ALGN
|
86.7 | $ 175.31 | 1.25 % | $ 13.1 B | USA |
 |
AdaptHealth Corp.
AHCO
|
43.8 | $ 12.36 | 1.56 % | $ 1.67 B | USA |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
66.9 | $ 282.75 | 1.3 % | $ 7.98 B | USA |
 |
Cytosorbents Corporation
CTSO
|
73.2 | $ 0.57 | -6.38 % | $ 35.5 M | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.32 | 0.61 % | $ 124 M |  France |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
57.3 | $ 38.08 | 1.3 % | $ 5.67 K | USA |
 |
Boston Scientific Corporation
BSX
|
65.7 | $ 62.05 | 0.47 % | $ 91.9 B | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
55.6 | $ 9.15 | 5.53 % | $ 259 M | USA |
 |
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
137 | $ 24.32 | 0.83 % | $ 206 M | USA |
 |
Helius Medical Technologies
HSDT
|
53.3 | $ 1.88 | -0.49 % | $ 1.14 M | USA |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | USA |
 |
Inogen
INGN
|
35.8 | $ 6.53 | 3.08 % | $ 174 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
IRIDEX Corporation
IRIX
|
47.5 | $ 0.99 | -0.99 % | $ 16.8 M | USA |
 |
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | USA |
 |
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 16.43 | 2.88 % | $ 385 M | USA |
 |
LivaNova PLC
LIVN
|
53.8 | $ 63.3 | 0.82 % | $ 3.45 B |  Britain |
 |
LENSAR
LNSR
|
38.9 | $ 5.85 | 2.63 % | $ 70 M | USA |
 |
Globus Medical
GMED
|
76.8 | $ 91.35 | 1.08 % | $ 12.4 B | USA |
 |
Butterfly Network
BFLY
|
76.1 | $ 4.14 | 0.98 % | $ 876 M | USA |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
48.5 | $ 10.24 | 1.99 % | $ 367 M | USA |
 |
Myomo
MYO
|
35.3 | $ 0.69 | 0.59 % | $ 28.9 M | USA |
 |
Inspire Medical Systems
INSP
|
42.6 | $ 54.15 | 0.28 % | $ 1.59 B | USA |
 |
CONMED Corporation
CNMD
|
64.5 | $ 36.61 | -0.35 % | $ 1.14 B | USA |
 |
NanoVibronix
NAOV
|
29.7 | - | - | $ 1.08 M | USA |
 |
Integer Holdings Corporation
ITGR
|
58.2 | $ 85.19 | 0.06 % | $ 2.96 B | USA |
 |
FONAR Corporation
FONR
|
237 | $ 18.63 | -0.29 % | $ 122 M | USA |